Placebos have been around for ages and are safe and effective in a pretty impressive amount of cases. Hopefully MDs will find the right place for them in their medicine cabinet. medscape.com/viewarticle/96…

Open-Label #Placebo Improves Symptoms in #Pediatric #IBS medscape.com/viewarticle/96…

Whole foods for the win #microbiome

Fake medicines kill hundreds of thousands each year. I looked into what's being done to tackle the problem. Patient education is key!! #fakemeds #patientsafety In Vivo, Citeline Commercial invivo.pharmaintelligence.informa.com/articles/2022/…

Great article by David Wild in @InVivo on the challenges of recruiting patients for rare disease trials. Read it to learn how #Pharnext employed effective strategies to overcome these hurdles. Link: bit.ly/3Bqucx6 #CharcotMarieTooth #RareDisease #CMT1A

We are always aiming to be the value add for our customers- to support their projects. Thanks David Wild and In Vivo, Citeline Commercial for capturing that spirit. invivo.pharmaintelligence.informa.com/IV146705/Twist…

Black Death may have influenced evolution of genes involved in immune responses, possibly increasing risk of #Crohns disease statnews.com/2022/10/19/bla… via STAT

It's a rare thing to see pharma competitors collaborate. In this article for In Vivo, Citeline Commercial, I report on one such collaboration, to improve the power of AI in drug discovery.

My first go as a podcast host! I enjoyed the process and this interview with Petra Jantzer of Accenture

Competition is fierce when it comes to finding diverse talent in biopharma! I spoke with folks at Gilead Sciences, Sanofi and 82VS about their strategies for attracting and retaining employees from traditionally underrepresented groups. invivo.pharmaintelligence.informa.com/articles/2022/…

With the ⁦U.S. FDA⁩ approval of #Rebyota, the era of standardized #microbiome treatments has begun. A look at the microbiome pipeline for recurrent C. difficile shows treatments becoming smarter and possibly safer. ⁦In Vivo, Citeline Commercial⁩ invivo.pharmaintelligence.informa.com/IV146795/Micro…

Look for @jessicaemerrill @scripmandy and David Wild reporting from JPM health care conf next week (and at the best parties!). Also, Jessica’s preview story is free to read. #JPM2023 #JPMorgan 2023

At #BiotechShowcase, Ovid Therapeutics CEO Jeremy Levin says the Inflation Reduction Act’s passage was a failure of the industry to educate voters and legislators. Good news is that framework for implementation is still up for negotiation.

“In a crowded AI-driven drug development sector, BenevolentAI stands out with its broad pipeline of drug candidates, deep pockets & growing partnership with AstraZeneca” Read David Wild’s In Vivo, Citeline Commercial article & interview with our Co-Founder, Ivan Griffin invivo.pharmaintelligence.informa.com/IV146802/The-S…

Over 10 data analyses at #DDW2023 strengthen the evidence base for use of AbbVie's Rinvoq In Crohn's scrip.pharmaintelligence.informa.com/articles/2023/… In Vivo, Citeline Commercial

During times of conflict and suffering, we can only hope that outsiders who are not immediately affected will nurture seeds of peace. The job of intellectuals, artists and scholars is to try and go deeper. To try and see the complexity of reality, especially in today's climate of

Sheer horror. This is not what resistance looks like

Today I was among the journalists who have attended a private screening of the raw footage of October 7th and I want to express to you what I saw since it’s not been made public. It’s been a very heavy day. A decision was made that Jews are less than human, and treated that way

Breaking news: The IDF has decided to stop it's fight against Hamas, because the city of Long Beach CA, where crime and homelesness have been rising at staggering rates, decided after a 6 hour meeting to vote for a ceasefire. There are many reasons to support this ceasefire,

The Grateful Dead's co-founder and bassist Phil Lesh has passed away. Tucker Carlson interviewed him many years ago: